CLINICAL_TRIALS
trial_result
· 2025-05-28
Clinical Trial Update: A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] [Phase 2]
Summary
Phase 2 study of LY3819469 in participants with elevated lipoprotein(a) has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Lipoprotein Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-05-28